Therapeutic options for Acinetobacter baumannii infections
Acinetobacter baumannii is an important cause of nosocomial infections, mainly in patients
in intensive care units. This microorganism, although with slight differences depending on …
in intensive care units. This microorganism, although with slight differences depending on …
Therapeutic options for Acinetobacter baumannii infections: an update
Introduction: Although the clinical importance of Acinetobacter pittii and Acinetobacter
nosocomialis has increased in the nosocomial setting in the last decade, infections caused …
nosocomialis has increased in the nosocomial setting in the last decade, infections caused …
Treatment of Acinetobacter baumannii severe infections
R Reina, C León-Moya, J Garnacho-Montero - Medicina Intensiva (English …, 2022 - Elsevier
Acinetobacter baumannii is a Gram-negative, multidrug-resistant (MDR) pathogen that
causes nosocomial infections, especially in intensive care units (ICUs) and …
causes nosocomial infections, especially in intensive care units (ICUs) and …
Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options
The first decade of the 20th century witnessed a surge in the incidence of infections due to
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter …
[HTML][HTML] A 5-year surveillance study on antimicrobial resistance of Acinetobacter baumannii clinical isolates from a tertiary Greek hospital
S Maraki, E Mantadakis, VE Mavromanolaki… - Infection & …, 2016 - ncbi.nlm.nih.gov
Background Acinetobacter baumannii has emerged as a major cause of nosocomial
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
NC Gordon, DW Wareham - International journal of antimicrobial agents, 2010 - Elsevier
Infection due to Acinetobacter baumannii has become a significant challenge to modern
healthcare systems. The organism shows a formidable capacity to develop antimicrobial …
healthcare systems. The organism shows a formidable capacity to develop antimicrobial …
Acinetobacter baumannii: an emerging multidrug-resistant threat
TD Gootz, A Marra - Expert review of anti-infective therapy, 2008 - Taylor & Francis
Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …
Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles
SRA Castilho, CSM Godoy, AO Guilarde, JL Cardoso… - PLoS …, 2017 - journals.plos.org
Resistance to antimicrobial agents is increasing worldwide and imposes significant life-
threatening risks to several different populations, especially those in intensive care units …
threatening risks to several different populations, especially those in intensive care units …
Molecular mechanisms of antimicrobial resistance in Acinetobacter baumannii, with a special focus on its epidemiology in Lebanon
S Jamal, A Al Atrouni, R Rafei, F Dabboussi… - Journal of global …, 2018 - Elsevier
Acinetobacter baumannii is an opportunistic bacterium involved in several types of infection
with high mortality and morbidity, especially in intensive care units. Treatment of these …
with high mortality and morbidity, especially in intensive care units. Treatment of these …
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
M Kempf, JM Rolain - International journal of antimicrobial agents, 2012 - Elsevier
Despite having a reputation of low virulence, Acinetobacter baumannii is an emerging
multidrug-resistant (MDR) pathogen responsible for community-and hospital-acquired …
multidrug-resistant (MDR) pathogen responsible for community-and hospital-acquired …